🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Poly(ADP-ribose) polymerase (PARP) inhibitors are anti-cancer treatments th...
Status
Recruiting
Location
Centre Hospitalier Universitaire d'Amiens Picardie Site Sud
Start Date
2024-09-24
Trial ID
NCT06572735
Treatments Being Tested
Niemann-Pick disease, type C (NPC) is a lethal, autosomal recessive, lysoso...
Status
Completed
Location
St. Louis Children's Hospital
Start Date
2019-02-22
Trial ID
NCT03471143
Treatments Being Tested
This prospective cohort study is part of the Clinnova programme and aims to...
Status
Recruiting
Location
Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB)
Start Date
2024-12-10
Trial ID
NCT06526364
Treatments Being Tested
The purpose of this study is to monitor safety outcomes for patients being ...
Status
Unknown
Location
Southeast Retina
Start Date
2013-03
Trial ID
NCT01790893
Treatments Being Tested
The main purpose of this study to determine the safety of an experimental m...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2017-01-19
Trial ID
NCT03030885
Treatments Being Tested
This study in patients suffering of Chronic Obstructive Pulmonary disease (...
Status
Completed
Location
Evang. Kliniken Essen-Mitte gGmbH
Start Date
2022-04-25
Trial ID
NCT05287555
Treatments Being Tested
This is a multisite prospective observational study to evaluate the clinica...
Status
Active Not Recruiting
Location
Children's National Hospital
Start Date
2021-07-23
Trial ID
NCT04830852
The goal of this interventional study is to test the feasibility of a new c...
Status
Recruiting
Location
University of North Carolina-Chapel Hill School of Medicine
Start Date
2024-02-05
Trial ID
NCT06186752
Treatments Being Tested
The purpose of this study is to evaluate the reactogenicity, safety and imm...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2019-10-25
Trial ID
NCT04006808
Treatments Being Tested
The most common growth-related injury is Osgood Schlatter, which affects up...
Status
Completed
Location
Hvidovre Hospital
Start Date
2022-01-01
Trial ID
NCT05174182
Treatments Being Tested